rs61998185

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_024781.3(CCDC102B):​c.78C>T​(p.Arg26Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00375 in 1,613,896 control chromosomes in the GnomAD database, including 175 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 102 hom., cov: 31)
Exomes 𝑓: 0.0020 ( 73 hom. )

Consequence

CCDC102B
NM_024781.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.318

Publications

1 publications found
Variant links:
Genes affected
CCDC102B (HGNC:26295): (coiled-coil domain containing 102B)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-68836841-C-T is Benign according to our data. Variant chr18-68836841-C-T is described in ClinVar as [Benign]. Clinvar id is 784380.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.318 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0673 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC102BNM_024781.3 linkc.78C>T p.Arg26Arg synonymous_variant Exon 2 of 8 ENST00000360242.9 NP_079057.3 Q68D86-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC102BENST00000360242.9 linkc.78C>T p.Arg26Arg synonymous_variant Exon 2 of 8 1 NM_024781.3 ENSP00000353377.5 Q68D86-1

Frequencies

GnomAD3 genomes
AF:
0.0201
AC:
3060
AN:
151988
Hom.:
102
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0695
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00858
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00515
AC:
1284
AN:
249270
AF XY:
0.00404
show subpopulations
Gnomad AFR exome
AF:
0.0710
Gnomad AMR exome
AF:
0.00353
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000398
Gnomad OTH exome
AF:
0.00248
GnomAD4 exome
AF:
0.00205
AC:
2990
AN:
1461790
Hom.:
73
Cov.:
32
AF XY:
0.00176
AC XY:
1280
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.0673
AC:
2254
AN:
33478
American (AMR)
AF:
0.00420
AC:
188
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39694
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86254
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53404
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5766
European-Non Finnish (NFE)
AF:
0.000232
AC:
258
AN:
1111948
Other (OTH)
AF:
0.00445
AC:
269
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
184
368
551
735
919
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0201
AC:
3064
AN:
152106
Hom.:
102
Cov.:
31
AF XY:
0.0197
AC XY:
1467
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0694
AC:
2879
AN:
41480
American (AMR)
AF:
0.00857
AC:
131
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5160
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10596
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
67990
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
148
296
445
593
741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00954
Hom.:
28
Bravo
AF:
0.0221
Asia WGS
AF:
0.00577
AC:
20
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000356

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
3.4
DANN
Benign
0.43
PhyloP100
-0.32
PromoterAI
0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61998185; hg19: chr18-66504078; API